Difficulties in choosing a biologic disease-modifying anti-rheumatic drug for the treatment of psoriasis and psoriatic arthritis

Author:

Marusenko I. M.1,Vezikova N. N.1,Kondrichin S. N.1,Silvestrov N. D.2

Affiliation:

1. Petrozavodsk State University, Medical Institute, Department of Hospital Therapy

2. V.A. Baranov Republican Hospital

Abstract

The article presents a clinical observation of a patient with severe psoriasis and psoriatic arthritis. Due to insufficient efficacy of systemic therapy of psoriasis biologic disease-modifying therapy was started, but it was associated with difficulties. Development of erythrodermic form of psoriasis was observed during treatment with infliximab and abatacept was successfully used though it is not registered inRussiafor the treatment of psoriasis.

Publisher

Mediar Press

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference39 articles.

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med. 2009;361(12):496-509. doi: 10.1056/NEJMra0804595

2. Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386:983-94. doi: 10.1016/S0140-6736(14)61909-7

3. Gladman DD. Clinical features and diagnostic considerations in psoriatic arthritis. Rheum Dis Clin North Am. 2015;41:569-79. doi: 10.1016/j.rdc.2015.07.003

4. Rossiiskoe obshchestvo dermatovenerologov i kosmetologov. Obshcherossiiskaya obshchestvennaya organizatsiya «Assotsiatsiya revmatologov Rossii». Federal'nye klinicheskie rekomendatsii po vedeniyu bol'nykh psoriaticheskim artritom. Moskva; 2015. S. 41 [Russian society of dermatovenerologists and cosmetologists. All-Russian public organization «Association of Rheumatologists of Russia». Federal clinical guidelines for the management of patients with psoriatic arthritis. Moscow; 2015. P. 41 (In Russ.)].

5. Mease P, Armstrong A. Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs. 2014;74:423-41. doi: 10.1007/s40265-014-0191-y

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3